---
title: 'Associate Director, Clinical Operations at Cogent Biosciences'
canonical: 'https://feeny.ai/job/associate-director-clinical-operations-cogent-biosciences-waltham-massachusetts-ae9494b3zdm7'
type: 'job'
last_seen: '2026-09-16'
---

# Associate Director, Clinical Operations at Cogent Biosciences

- **Company:** Cogent Biosciences
- **Location:** Waltham Massachusetts, United States
- **Posted:** 2026-07-21
- **Last confirmed live:** 2026-09-16
- **Apply:** https://job-boards.greenhouse.io/cogentbiosciences/jobs/4323989009

## Job description

Who We Are:

Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.

The Role:

Cogent Biosciences is seeking an experienced and highly motivated Associate Director, Clinical Operations to serve as a key operational leader across our clinical development programs. Reporting to the Senior Director, Head of Clinical Operations, this individual will function as both a hands-on study leader and a strategic clinical operations partner, helping drive execution and operational excellence across multiple stages of development.

This role is ideal for someone who enjoys balancing operational detail with strategic program oversight—an individual who can independently lead complex global studies while also contributing to broader Clinical Operations strategy, portfolio planning, process improvement, and cross-functional decision-making.

The successful candidate will be accountable for the planning, execution, oversight, and delivery of clinical trials across early-stage development programs, with opportunities to support later-stage development as programs advance. This individual will serve as a trusted partner to the Head of Clinical Operations and will be expected to identify risks proactively, influence key stakeholders, and help scale operational excellence within a growing clinical organization.

We are seeking someone who brings strong operational expertise, a sense of ownership, intellectual curiosity, and a willingness to work at both the strategic and tactical levels. The ideal candidate is equally comfortable reviewing site-level enrollment challenges, leading vendor governance discussions, influencing development strategy teams, and driving complex cross-functional initiatives.

Responsibilities:

-

- Serve as the clinical operations lead for one or more global clinical studies, ensuring delivery of study objectives on timeline, budget, and quality expectations. Provide strategic oversight of CROs and vendors, ensuring accountability, quality, and operational execution.
- Develop and review study performance metrics and drive corrective and preventive actions when needed. Evaluate and analyze site trends, evaluate study risks and mitigation strategies, and work with the cross-functional team in the review clinical data.
- Develop strong partnerships with external stakeholders while maintaining sponsor ownership of study execution. Serve as Clinical Operations representative on Strategy Teams, and coordinate and lead study team meetings and update the cross-functional Team on timelines and milestones for the study.
- Contribute to the development of study documentation including protocol review, creating study manuals, ICFs, designing CRFs, and ensure proper team and external training.
- Provide input to Clinical Study Reports and Investigator Brochures, including data cleaning, listing review, and report writing.
- Support the evaluation of study vendors, including negotiation of contracts and budgets with CROs, clinical sites and vendors
- Perform clinical research site activities, such as onsite or remote monitoring, co-monitoring, training, motivational, and sponsor oversight visits, as needed
- Ensure that study documentation is maintained according to applicable regulations, industry accepted standards, and SOPs that govern clinical studies both in the field and in-house.
- Collaborate with Clinical, Regulatory, and Quality team members to ensure compliance of department/study activities with FDA regulations, guidelines, and principles of ICH GCP and company SOPs.
- Limited travel possible to clinical sites for investigator and site engagement, with potential to travel  (~25%).

Qualifications:

-

- BS/BA Degree or equivalent in science or a health-related field is preferred
- Minimum 6-7+ years of relevant industry clinical development experience
- Experience with complex therapeutic platforms
- Multi-phase clinical trials
- Experience with all aspects of trial and site startup and vendor selection and management, study management, and monitoring
- Familiarity with clinical data review and data management processes
- Excellent knowledge of GCP, ICH, and FDA regulations
- Experience with SOP review and development

Salary Range:

$185,000- $215,000USD

Target Bonus: 20%

Exact compensation will vary based on skills, experience, and location.

Our Locations

Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.

Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.

Our Offer To You

At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

## About Cogent Biosciences

## Company Overview
- **One-liner**: Cogent Biosciences is a publicly traded biotechnology company developing precision therapies for genetically defined diseases, with its lead program bezuclastinib targeting KIT D816V mutations in systemic mastocytosis and gastrointestinal stromal tumors.
- **Entity Type**: Public (NASDAQ: COGT)
- **Headquarters**: Waltham, Massachusetts, United States (with additional office in Boulder, Colorado)
- **Founded**: 2014
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology research and therapeutics development
- **Target customers**: Patients with genetically defined diseases, healthcare providers, and pharmaceutical partners (B2B/B2C hybrid)
- **Mission**: “To discover, develop, and commercialize best-in-class therapies that have a dramatic impact for patients with genetically defined diseases” [cogentbio.com](https://www.cogentbio.com/)

## Products & Services
- **Bezuclastinib**: A selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation and other KIT exon 17 mutations. In late-stage clinical development for advanced systemic mastocytosis (AdvSM), non‑advanced SM, and advanced gastrointestinal stromal tumors (GIST). Positive registration‑directed trial results reported in 2025. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Novel JAK2 V617F inhibitor**: A potential best‑in‑class mutant‑selective JAK2 inhibitor currently in preclinical development, with data presented at the 2026 EHA Congress. [cogentbio.com](https://www.cogentbio.com/)
- **Additional pipeline programs**: Research‑stage targeted therapies addressing mutations in ErbB2, PI3Kα, KRAS, and JAK2. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Market Standing
- **Valuation/Market Cap**: USD $762.7 million (as of mid‑2026, based on LinkedIn data) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Key Metric**: Annual revenue of USD $7.9 million (likely from partnerships or grants); total funding to date ~USD $1.82 billion (including post‑IPO equity, debt, and Series A). [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Notable Investors/Partners**: Series A led by Atlas Venture and F‑Prime; post‑IPO equity rounds led by Commodore Capital (2024, $225M), Fairmount Funds Management (2020, $104.4M) [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)
- **Growth Signals**: Headcount grew 27.6% year‑over‑year to 223 employees; monthly LinkedIn follower growth of 3.0% (+61.7% annually); positive late‑stage trial results in 2025; expanded pipeline with new preclinical assets. [linkedin.com](https://www.linkedin.com/company/cogentbiosciences)

## Competitive Advantages
- **Selective targeting of KIT D816V**: Bezuclastinib is designed to selectively and potently inhibit the key driver mutation in systemic mastocytosis, potentially offering a better safety/tolerability profile than earlier multi‑kinase inhibitors.
- **Late‑stage momentum**: Registration‑directed trials (APEX pivotal trial) have reported clinically meaningful results, positioning the company for potential regulatory submissions and commercialization.
- **Broad pipeline beyond KIT**: Research into JAK2, KRAS, PI3Kα, and ErbB2 mutations diversifies the platform and reduces single‑asset risk.
- **Strong capital position**: Over $760M market cap and access to public equity markets provide financial runway for multiple programs.

## Strategic Focus
- **Advance bezuclastinib to market**: Continue regulatory interactions and preparation for potential FDA approval in AdvSM and GIST, while expanding into non‑advanced SM.
- **Build a portfolio of precision therapies**: Invest in early‑stage discovery (Boulder, CO) to generate novel molecules targeting validated oncogenic drivers.
- **Commercial readiness**: Hiring commercial leadership (Chief Commercial Officer, Market Access, Field Medical Affairs) indicates preparation for a future product launch. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)

## Why Work Here
- **Culture**: Emphasizes collaboration, urgency, inquisitiveness, and ingenuity. Corporate values include “Patients are waiting” (urgency), “Learning excites us” (inquisitiveness), “Succeed Together” (trust), and “Navigate uncertainty” (ingenuity). [cogentbio.com](https://www.cogentbio.com/careers/)
- **Work model**: Hybrid/remote flexibility – many roles are listed as remote (e.g., Area Directors for Field Medical Affairs, Patient Educators), while research roles are onsite in Boulder, CO. [greenhouse.io](https://job-boards.greenhouse.io/cogentbiosciences)
- **Growth and impact**: As a late‑stage clinical company with an expanding pipeline, employees have direct influence on programs that could change patient lives. Fast‑paced environment with high autonomy.

## Sources
1. [Cogent Biosciences Corporate Website](https://www.cogentbio.com/)
2. [Cogent Biosciences About Page](https://www.cogentbio.com/about/)
3. [Cogent Biosciences Careers Page](https://www.cogentbio.com/careers/)
4. [Cogent Biosciences Job Board (Greenhouse)](https://job-boards.greenhouse.io/cogentbiosciences)
5. [Cogent Biosciences LinkedIn Profile](https://www.linkedin.com/company/cogentbiosciences)

## Other roles at Cogent Biosciences

- [Research Associate, Pharmacology & Cell Biology](https://feeny.ai/job/research-associate-pharmacology-cell-biology-cogent-biosciences-boulder-colorado-6t4r2c47nb6t) — Boulder Colorado, United States
- [Associate Director, Translational Medicine](https://feeny.ai/job/associate-director-translational-medicine-cogent-biosciences-waltham-rj8yex8parvp) — Waltham Massachusetts, United States
- [Director, Corporate Counsel](https://feeny.ai/job/director-corporate-counsel-cogent-biosciences-waltham-massachusetts-re6398tj5cwt) — Waltham Massachusetts, United States
- [Senior Manager, Medical Information](https://feeny.ai/job/senior-manager-medical-information-cogent-biosciences-united-states-je8kfksdfe70) — United States
- [Senior Manager, Quality Control GMP](https://feeny.ai/job/senior-manager-quality-control-gmp-cogent-biosciences-united-states-wdgyhgjzbkmw) — United States
- [Director, Drug Substance Manufacturing & Development](https://feeny.ai/job/director-drug-substance-manufacturing-development-cogent-biosciences-united-3xsj3y1318p1) — United States
- [Associate Director, Patient Marketing](https://feeny.ai/job/associate-director-patient-marketing-cogent-biosciences-waltham-massachusetts-rfrx7rz2grmj) — Waltham Massachusetts, United States
- [Senior Medical Science Liaison - Midwest (Detroit, Minneapolis, Central Plains)](https://feeny.ai/job/senior-medical-science-liaison-midwest-detroit-minneapolis-central-plains-6y8fsqpt0n2k) — United States
- [Principal Scientist, Computational Chemistry](https://feeny.ai/job/principal-scientist-computational-chemistry-cogent-biosciences-boulder-colorado-f1xwrgthyhmq) — Boulder Colorado, United States
- [Desktop and Field Sales Support Specialist](https://feeny.ai/job/desktop-and-field-sales-support-specialist-cogent-biosciences-waltham-m2sxf462656q) — Waltham Massachusetts, United States